Literature DB >> 8853176

Widespread cutaneous necrosis associated with antiphospholipid syndrome.

I M Jou1, M F Liu, S C Chao.   

Abstract

Widespread cutaneous necrosis as the catastrophic manifestation in antiphospholipid syndrome (APLS) is rather uncommon. Even in the few documented cases, the extensive skin necrosis lesions have been stabilized and regressed with eventual healing utilizing pulse steroid therapy alone or in conjunction with further treatment with plasmapheresis. We describe one case of APLS associated with lupus-like disease. The young female suffered from widespread cutaneous necrosis of the lower legs and gangrene change in the digital end of hands and feet. This condition necessitated amputation of major lower extremities and digital amputation of both hands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853176     DOI: 10.1007/bf02230365

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Gangrene as a manifestation of systemic lupus erythematosus.

Authors:  E L DUBOIS; J D ARTERBERRY
Journal:  JAMA       Date:  1962-08-04       Impact factor: 56.272

2.  Widespread cutaneous necrosis associated with cardiolipin antibodies.

Authors:  A O'Neill; P A Gatenby; B McGaw; D M Painter; P R McKenzie
Journal:  J Am Acad Dermatol       Date:  1990-02       Impact factor: 11.527

3.  Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies.

Authors:  P Wolf; H P Soyer; P Auer-Grumbach; H Kerl
Journal:  Arch Dermatol       Date:  1991-11

4.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

5.  Widespread cutaneous necrosis associated with the lupus anticoagulant.

Authors:  H J Dodd; I Sarkany; D O'Shaughnessy
Journal:  Clin Exp Dermatol       Date:  1985-11       Impact factor: 3.470

6.  The Prosser-White oration 1983. Connective tissue disease and the skin.

Authors:  G R Hughes
Journal:  Clin Exp Dermatol       Date:  1984-11       Impact factor: 3.470

7.  Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin.

Authors:  G J Ruiz-Arguelles; A Ruiz-Arguelles; M Deleze; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

8.  Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; M E Pérez-Vázquez; A R Villa; C Drenkard; J Cabiedes
Journal:  Semin Arthritis Rheum       Date:  1992-04       Impact factor: 5.532

9.  Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus.

Authors:  M S Amster; J Conway; M Zeid; S Pincus
Journal:  J Am Acad Dermatol       Date:  1993-11       Impact factor: 11.527

10.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec
View more
  2 in total

Review 1.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

2.  Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.

Authors:  Rubens Costa; Salman Fazal; Robert B Kaplan; Joel Spero; Ricardo Costa
Journal:  Clin Rheumatol       Date:  2010-06-17       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.